157 related articles for article (PubMed ID: 21765445)
1. Rosiglitazone protects neuroblastoma cells against advanced glycation end products-induced injury.
Wang L; Yu CJ; Liu W; Cheng LY; Zhang YN
Acta Pharmacol Sin; 2011 Aug; 32(8):991-8. PubMed ID: 21765445
[TBL] [Abstract][Full Text] [Related]
2. Diosmetin Targeted at Peroxisome Proliferator-Activated Receptor Gamma Alleviates Advanced Glycation End Products Induced Neuronal Injury.
Lai MC; Liu WY; Liou SS; Liu IM
Nutrients; 2022 May; 14(11):. PubMed ID: 35684047
[TBL] [Abstract][Full Text] [Related]
3. The Citrus Flavonoid Hesperetin Encounters Diabetes-Mediated Alzheimer-Type Neuropathologic Changes through Relieving Advanced Glycation End-Products Inducing Endoplasmic Reticulum Stress.
Lai MC; Liu WY; Liou SS; Liu IM
Nutrients; 2022 Feb; 14(4):. PubMed ID: 35215394
[TBL] [Abstract][Full Text] [Related]
4. The neuroprotective role of rosiglitazone in advanced glycation end product treated human neural stem cells is PPARgamma-dependent.
Chiang MC; Cheng YC; Nicol CJ; Lin CH
Int J Biochem Cell Biol; 2017 Nov; 92():121-133. PubMed ID: 28964868
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of (-)-epigallocatechin gallate against advanced glycation endproducts-induced injury in neuronal cells.
Lee SJ; Lee KW
Biol Pharm Bull; 2007 Aug; 30(8):1369-73. PubMed ID: 17666787
[TBL] [Abstract][Full Text] [Related]
6. Antineoplastic effects of rosiglitazone and PPARgamma transactivation in neuroblastoma cells.
Cellai I; Benvenuti S; Luciani P; Galli A; Ceni E; Simi L; Baglioni S; Muratori M; Ottanelli B; Serio M; Thiele CJ; Peri A
Br J Cancer; 2006 Oct; 95(7):879-88. PubMed ID: 16969347
[TBL] [Abstract][Full Text] [Related]
7. Rosiglitazone protects human neuroblastoma SH-SY5Y cells against MPP+ induced cytotoxicity via inhibition of mitochondrial dysfunction and ROS production.
Jung TW; Lee JY; Shim WS; Kang ES; Kim SK; Ahn CW; Lee HC; Cha BS
J Neurol Sci; 2007 Feb; 253(1-2):53-60. PubMed ID: 17266988
[TBL] [Abstract][Full Text] [Related]
8. Protective role of activating PPARγ in advanced glycation end products-induced impairment of coronary artery vasodilation via inhibiting p38 phosphorylation and reactive oxygen species production.
Hua B; Liu Q; Gao S; Li W; Li H
Biomed Pharmacother; 2022 Mar; 147():112641. PubMed ID: 35051861
[TBL] [Abstract][Full Text] [Related]
9. Rosiglitazone inhibits metastasis development of a murine mammary tumor cell line LMM3.
Magenta G; Borenstein X; Rolando R; Jasnis MA
BMC Cancer; 2008 Feb; 8():47. PubMed ID: 18261208
[TBL] [Abstract][Full Text] [Related]
10. Rosiglitazone via upregulation of Akt/eNOS pathways attenuates dysfunction of endothelial progenitor cells, induced by advanced glycation end products.
Liang C; Ren Y; Tan H; He Z; Jiang Q; Wu J; Zhen Y; Fan M; Wu Z
Br J Pharmacol; 2009 Dec; 158(8):1865-73. PubMed ID: 19917066
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor gamma up-regulates the Bcl-2 anti-apoptotic protein in neurons and induces mitochondrial stabilization and protection against oxidative stress and apoptosis.
Fuenzalida K; Quintanilla R; Ramos P; Piderit D; Fuentealba RA; Martinez G; Inestrosa NC; Bronfman M
J Biol Chem; 2007 Dec; 282(51):37006-15. PubMed ID: 17965419
[TBL] [Abstract][Full Text] [Related]
12. An Extract from Shrimp Processing By-Products Protects SH-SY5Y Cells from Neurotoxicity Induced by Aβ
Zhang Y; Jiao G; Song C; Gu S; Brown RE; Zhang J; Zhang P; Gagnon J; Locke S; Stefanova R; Pelletier C; Zhang Y; Lu H
Mar Drugs; 2017 Mar; 15(3):. PubMed ID: 28327516
[TBL] [Abstract][Full Text] [Related]
13. Oroxylum indicum (L.) extract protects human neuroblastoma SH‑SY5Y cells against β‑amyloid‑induced cell injury.
Mairuae N; Connor JR; Buranrat B; Lee SY
Mol Med Rep; 2019 Aug; 20(2):1933-1942. PubMed ID: 31257498
[TBL] [Abstract][Full Text] [Related]
14. Rosiglitazone activation of PPARγ-dependent pathways is neuroprotective in human neural stem cells against amyloid-beta-induced mitochondrial dysfunction and oxidative stress.
Chiang MC; Nicol CJ; Cheng YC; Lin KH; Yen CH; Lin CH
Neurobiol Aging; 2016 Apr; 40():181-190. PubMed ID: 26973118
[TBL] [Abstract][Full Text] [Related]
15. Rosiglitazone inhibits chlorpyrifos-induced apoptosis via modulation of the oxidative stress and inflammatory response in SH-SY5Y cells.
Lee JE; Park JH; Jang SJ; Koh HC
Toxicol Appl Pharmacol; 2014 Jul; 278(2):159-71. PubMed ID: 24793810
[TBL] [Abstract][Full Text] [Related]
16. Rosiglitazone protects human neuroblastoma SH-SY5Y cells against acetaldehyde-induced cytotoxicity.
Jung TW; Lee JY; Shim WS; Kang ES; Kim SK; Ahn CW; Lee HC; Cha BS
Biochem Biophys Res Commun; 2006 Feb; 340(1):221-7. PubMed ID: 16360119
[TBL] [Abstract][Full Text] [Related]
17. PPARgamma agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms.
Yi JH; Park SW; Brooks N; Lang BT; Vemuganti R
Brain Res; 2008 Dec; 1244():164-72. PubMed ID: 18948087
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effects of salidroside against beta-amyloid-induced oxidative stress in SH-SY5Y human neuroblastoma cells.
Zhang L; Yu H; Zhao X; Lin X; Tan C; Cao G; Wang Z
Neurochem Int; 2010 Nov; 57(5):547-55. PubMed ID: 20615444
[TBL] [Abstract][Full Text] [Related]
19. PPAR-γ activation attenuates deltamethrin-induced apoptosis by regulating cytosolic PINK1 and inhibiting mitochondrial dysfunction.
Ko J; Park JH; Park YS; Koh HC
Toxicol Lett; 2016 Oct; 260():8-17. PubMed ID: 27553674
[TBL] [Abstract][Full Text] [Related]
20. Effect of rosiglitazone on amyloid precursor protein processing and Aβ clearance in streptozotocin-induced rat model of Alzheimer's disease.
Wang L; Liu W; Fan Y; Liu T; Yu C
Iran J Basic Med Sci; 2017 May; 20(5):474-480. PubMed ID: 28656081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
